durvalumab
astrazeneca,orpathys
['calypso']
calypso trial presented by at #asco22 not achieved the primary end point!
molecular analysis : met might be prognostic. 
Oncólogo Clínico staff @IAF_Fleming. Miembro @SelnetH2020 @aaoncoclinica. Interesado en #GUcsm. #clinicaltrials. #Immunotherapy #PrecisionMedicine #oncoalert